{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:23:53Z","timestamp":1773221033601,"version":"3.50.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","award":["- IF190945"],"award-info":[{"award-number":["- IF190945"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/002158"],"award-info":[{"award-number":["CRG\/2020\/002158"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.compbiomed.2025.111134","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:24:27Z","timestamp":1759955067000},"page":"111134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PA","title":["Identification of effective cyclin-dependent kinase 3\/cyclin E inhibitors using multi-level computational screening and simulation"],"prefix":"10.1016","volume":"198","author":[{"given":"Srutishree","family":"Sarma","sequence":"first","affiliation":[]},{"given":"Dikshita","family":"Dowerah","sequence":"additional","affiliation":[]},{"given":"Shilpa","family":"Neog","sequence":"additional","affiliation":[]},{"given":"Nishant","family":"Biswakarma","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0666-4211","authenticated-orcid":false,"given":"Priyanka","family":"Dutta","sequence":"additional","affiliation":[]},{"given":"Gaurisankar","family":"Phukan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4352-2661","authenticated-orcid":false,"given":"Ramesh Ch.","family":"Deka","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/cancers7010179","article-title":"Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors","volume":"7","author":"Peyressatre","year":"2015","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.111134_bib2","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/ijms21061960","article-title":"The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer","volume":"21","author":"Ding","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.compbiomed.2025.111134_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbrc.2023.04.026","article-title":"Structural basis of CDK3 activation by cyclin E1 and inhibition by dinaciclib","volume":"662","author":"Gui","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.111134_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.100992","article-title":"Theileria annulata Hijacks host signaling: integrated phosphoproteomics and transcriptomics unveils ERK1\/2 as a central regulator of host transcription factors","volume":"24","author":"Dandasena","year":"2025","journal-title":"Mol. Cell. Proteomics"},{"issue":"30","key":"10.1016\/j.compbiomed.2025.111134_bib6","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1038\/onc.2014.430","article-title":"MiR-873 regulates ER\u03b1 transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells","volume":"34","author":"Cui","year":"2015","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.compbiomed.2025.111134_bib7","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/onc.2016.434","article-title":"Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer","volume":"36","author":"Xiao","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.compbiomed.2025.111134_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.mce.2015.01.016","article-title":"Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer","volume":"418","author":"Anbalagan","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.111134_bib9","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.18632\/oncotarget.6875","article-title":"Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"issue":"49","key":"10.1016\/j.compbiomed.2025.111134_bib10","doi-asserted-by":"crossref","first-page":"84917","DOI":"10.18632\/oncotarget.18171","article-title":"CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt\/\u03b2-catenin pathway","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2025.111134_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106249","article-title":"An overview of CDK3 in cancer: clinical significance and pharmacological implications","volume":"180","author":"Teo","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.111134_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10081","article-title":"Verification of cell cycle-associated cyclin-dependent kinases facilitated prostate cancer progression by integrated bioinformatic analysis and experimental validation","volume":"8","author":"Huang","year":"2022","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111134_bib13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1096\/fj.201700461RR","article-title":"miR\u2010125a\u20103p inhibits ER\u03b1 transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor\u2013positive breast cancer","volume":"32","author":"Zheng","year":"2018","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.111134_bib14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.chembiol.2012.06.015","article-title":"An integrated chemical biology approach provides insight into Cdk2 functional redundancy and inhibitor sensitivity","volume":"19","author":"Echalier","year":"2012","journal-title":"Chem. Biol."},{"issue":"23","key":"10.1016\/j.compbiomed.2025.111134_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312675","article-title":"Adamantane-substituted purines and their \u03b2-Cyclodextrin complexes: synthesis and biological activity","volume":"22","author":"Rouchal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2025.111134_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105296","article-title":"The CDK1 inhibitor, Ro-3306, is a potential antiviral candidate against influenza virus infection","volume":"201","author":"Zhao","year":"2022","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111134_bib17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/med.21856","article-title":"Analyzing the scaffold diversity of cyclin\u2010dependent kinase inhibitors and revisiting the clinical and preclinical pipeline","volume":"42","author":"Bhurta","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.111134_bib18","first-page":"1913","article-title":"CDK inhibitors in cancer therapy, an overview of recent development","volume":"11","author":"Zhang","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"23","key":"10.1016\/j.compbiomed.2025.111134_bib19","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1182\/blood.V126.23.4171.4171","article-title":"A phase 3 study to evaluate the efficacy and safety of dinaciclib compared to ofatumumab in patients with refractory chronic lymphocytic leukemia","volume":"126","author":"Ghia","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/ijmm.2017.2989","article-title":"The Cdc2\/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18\/stathmin in non-small cell lung cancer cells in vitro","volume":"40","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/CAD.0000000000001339","article-title":"Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer","volume":"34","author":"Zhang","year":"2023","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.compbiomed.2025.111134_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110723","article-title":"BRK confers tamoxifen-resistance in breast cancer via regulation of tyrosine phosphorylation of CDK1","volume":"108","author":"Mandapati","year":"2023","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111134_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drudis.2019.12.001","article-title":"Targeting CDK2 in cancer: challenges and opportunities for therapy","volume":"25","author":"Tadesse","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"15","key":"10.1016\/j.compbiomed.2025.111134_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512375","article-title":"Inhibition of CDK1 by RO-3306 exhibits anti-tumorigenic effects in ovarian cancer cells and a transgenic mouse model of ovarian cancer","volume":"24","author":"Huang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.111134_bib25","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1158\/0008-5472.CAN-20-3580","article-title":"Integrated screens identify CDK1 as a therapeutic target in advanced gastrointestinal stromal tumors","volume":"81","author":"Lu","year":"2021","journal-title":"Cancer Res."},{"issue":"31","key":"10.1016\/j.compbiomed.2025.111134_bib26","doi-asserted-by":"crossref","first-page":"49481","DOI":"10.18632\/oncotarget.10373","article-title":"Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.111134_bib27","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/ijms26052197","article-title":"Dinaciclib interrupts cell cycle and induces apoptosis in oral squamous cell carcinoma: mechanistic insights and therapeutic potential","volume":"26","author":"Oner","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75578-5","article-title":"Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2\/5\/9","volume":"10","author":"Saqub","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.111134_bib29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s11030-024-10939-0","article-title":"Identification of the potential Pan-CDK antagonists: tracing the path of virtual screening and inhibitory activity on lung cancer cells","volume":"29","author":"Tao","year":"2024","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13065-025-01459-5","article-title":"Synthesis of thiazoloquinolinone derivatives: molecular docking, MD simulation, and pharmacological evaluation as VEGFR-2 inhibitors","volume":"19","author":"Amiri","year":"2025","journal-title":"BMC Chem."},{"key":"10.1016\/j.compbiomed.2025.111134_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2025.1525533","article-title":"Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation","volume":"5","author":"Gheidari","year":"2025","journal-title":"Front. Drug Discov."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.111134_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nsb0902-646","article-title":"Molecular dynamics simulations of biomolecules","volume":"9","author":"Karplus","year":"2002","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.compbiomed.2025.111134_bib33","series-title":"Dosage Form Design Parameters","first-page":"731","article-title":"Computer-aided prediction of pharmacokinetic (ADMET) properties","author":"Chandrasekaran","year":"2018"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41598-023-50660-w","article-title":"DFT study, and natural bond orbital (NBO) population analysis of 2-(2-Hydroxyphenyl)-1-azaazulene tautomers and their mercapto analogues","volume":"14","author":"Halim","year":"2024","journal-title":"Sci. Rep."},{"issue":"25","key":"10.1016\/j.compbiomed.2025.111134_bib35","doi-asserted-by":"crossref","first-page":"22382","DOI":"10.1021\/acsomega.2c07860","article-title":"Design of LNA analogues using a combined density functional theory and molecular dynamics approach for RNA therapeutics","volume":"8","author":"Dowerah","year":"2023","journal-title":"ACS Omega"},{"issue":"15","key":"10.1016\/j.compbiomed.2025.111134_bib36","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1021\/jacs.1c11506","article-title":"Improving results by improving densities: density-corrected density functional theory","volume":"144","author":"Sim","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.compbiomed.2025.111134_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140702","article-title":"Novel 4-((3-fluorobenzyl) oxy) benzohydrazide derivatives as promising anti-prostate cancer agents: synthesis, characterization and in vitro & in silico biological activity studies","volume":"1322","author":"\u00c7ak\u0131r","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111134_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.compbiomed.2008.11.004","article-title":"Molecular modeling and dynamics simulation of human cyclin-dependent kinase 3 complexed with inhibitors","volume":"39","author":"Perez","year":"2009","journal-title":"Comput. Biol. Med."},{"issue":"2\u20103","key":"10.1016\/j.compbiomed.2025.111134_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/minf.201000143","article-title":"Structural bioinformatics approach of cyclin\u2010dependent kinases 1 and 3 complexed with inhibitors","volume":"30","author":"Saraiva","year":"2011","journal-title":"Mol. Inform."},{"key":"10.1016\/j.compbiomed.2025.111134_bib40","series-title":"Convergence of Technology & Biology-Transforming Life Sciences","first-page":"92","article-title":"Evaluating the potential of SHOC2, CDK3, and EGFR as drug target in lung cancer through in-silico studies","author":"Kanchana","year":"2025"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib41","article-title":"Chemical composition and anticancer activity of Psychotria Montana on MCF7 breast cancer cells: insights from in vitro (2D & 3D) studies and in silico analysis","volume":"23","author":"Nguyen","year":"2025","journal-title":"J. Appl. Biomed."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111134_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/ijmr.IJMR_51_16","article-title":"C-glycosyl flavone from Urginea indica inhibits proliferation & angiogenesis & induces apoptosis via cyclin-dependent kinase 6 in human breast, hepatic & colon cancer cell lines","volume":"147","author":"Bevara","year":"2018","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.111134_bib43","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11224-022-01958-4","article-title":"Identification of potent, non-toxic, selective CDK2 inhibitor through the pharmacophore-based scaffold hopping, molecular dynamics simulation-assisted molecular docking study, Lee Richard contour map analysis, and ADMET properties","volume":"33","author":"Chaube","year":"2022","journal-title":"Struct. Chem."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.111134_bib44","doi-asserted-by":"crossref","first-page":"D564","DOI":"10.1093\/nar\/gkae1091","article-title":"Updated resources for exploring experimentally-determined PDB structures and computed structure models at the RCSB protein data bank","volume":"53","author":"Burley","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.compbiomed.2025.111134_bib45","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.111134_bib46","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.111134_bib47","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1080\/07391102.2016.1196152","article-title":"Virtual screening of Piperine analogs as Survivin inhibitors and their molecular interaction analysis by using consensus docking, MD simulation, MMPB\/GBSA and alanine scanning techniques","volume":"35","author":"Sattarinezhad","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"16","key":"10.1016\/j.compbiomed.2025.111134_bib48","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111134_bib49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.111134_bib50","author":"Schr\u00f6dinger"},{"key":"10.1016\/j.compbiomed.2025.111134_bib51","series-title":"BIOVIA Discovery Studio Visualizer, v20.1.0.19295","year":"2019"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"37","key":"10.1016\/j.compbiomed.2025.111134_bib53","doi-asserted-by":"crossref","first-page":"26897","DOI":"10.1039\/D4RA03965C","article-title":"Artificial intelligence-aiding lab-on-a-chip workforce designed oral [3.1.0] bi and [4.2.0] tricyclic catalytic interceptors inhibiting multiple SARS-CoV-2 protomers assisted by double-shell deep learning","volume":"14","author":"Kalasin","year":"2024","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.111134_bib54","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/acs.jcim.3c02038","article-title":"ADMET-PrInt: evaluation of ADMET properties: prediction and interpretation","volume":"64","author":"Jamrozik","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.111134_bib55","series-title":"Computational Methods for Rational Drug Design","first-page":"123","article-title":"ADMET and physicochemical assessments in drug design","author":"\u00c7evik","year":"2025"},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.111134_bib56","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111134_bib57","series-title":"Gaussian 09 Revision D.01","author":"Frisch","year":"2016"},{"issue":"23","key":"10.1016\/j.compbiomed.2025.111134_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314719","article-title":"Testing of exchange-correlation functionals of DFT for a reliable description of the electron density distribution in organic molecules","volume":"23","author":"Domaga\u0142a","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.compbiomed.2025.111134_bib59","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1021\/jacs.1c11506","article-title":"Improving results by improving densities: density-corrected density functional theory","volume":"144","author":"Sim","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.compbiomed.2025.111134_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.132259","article-title":"Structural, spectroscopic, quantum chemical, and molecular docking investigation of (E)-N'-(2, 5-dimethoxybenzylidene) picolinohydrazide","volume":"1253","author":"Kavitha","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.111134_bib61","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1039\/D3CP04412B","article-title":"A density functional theory benchmark on antioxidant-related properties of polyphenols","volume":"26","author":"Mendes","year":"2024","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"24","key":"10.1016\/j.compbiomed.2025.111134_bib62","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1021\/acs.jctc.4c01283","article-title":"From implicit to explicit: an interaction-reorganization approach to molecular solvation energy","volume":"20","author":"Huang","year":"2024","journal-title":"J. Chem. Theory Comput."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.111134_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00214-021-02799-w","article-title":"Assessing the performances of different continuum solvation models for the calculation of hydration energies of molecules, polymers and surfaces: a comparison between the SMD, VASPsol and FDPB models","volume":"140","author":"O\u011fuz","year":"2021","journal-title":"Theor. Chem. Acc."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.111134_bib64","doi-asserted-by":"crossref","DOI":"10.1063\/5.0216272","article-title":"A comprehensive electron wavefunction analysis toolbox for chemists, Multiwfn","volume":"161","author":"Lu","year":"2024","journal-title":"J. Chem. Phys."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.111134_bib65","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1021\/acsomega.2c07148","article-title":"Theoretical investigation of para-amino-dichloro chalcone isomers. Part II: a DFT structure\u2013stability study of the FMO and NLO properties","volume":"8","author":"Hussein","year":"2023","journal-title":"ACS Omega"},{"issue":"25","key":"10.1016\/j.compbiomed.2025.111134_bib66","doi-asserted-by":"crossref","first-page":"22382","DOI":"10.1021\/acsomega.2c07860","article-title":"Design of LNA analogues using a combined density functional theory and molecular dynamics approach for RNA therapeutics","volume":"8","author":"Dowerah","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiomed.2025.111134_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107945","article-title":"Structural insight into locked nucleic acid based novel antisense modifications: a DFT calculations at monomer and MD simulations at oligomer level","volume":"107","author":"Uppuladinne","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.compbiomed.2025.111134_bib68","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.111134_bib69","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J. Chem. Theory Comput."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.111134_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1347","article-title":"Water models for biomolecular simulations","volume":"8","author":"Onufriev","year":"2018","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"issue":"20","key":"10.1016\/j.compbiomed.2025.111134_bib71","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1016\/j.bmc.2016.06.034","article-title":"Parametrization of halogen bonds in the CHARMM general force field: improved treatment of ligand\u2013protein interactions","volume":"24","author":"Guti\u00e9rrez","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111134_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.120116","article-title":"Effects of thermostats\/barostats on physical properties of liquids by molecular dynamics simulations","volume":"365","author":"Ke","year":"2022","journal-title":"J. Mol. Liq."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.111134_bib73","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/acs.jctc.2c01032","article-title":"Optimal bond constraint topology for molecular dynamics simulations of cholesterol","volume":"19","author":"F\u00e1bi\u00e1n","year":"2023","journal-title":"J. Chem. Theory Comput."},{"issue":"37","key":"10.1016\/j.compbiomed.2025.111134_bib74","doi-asserted-by":"crossref","first-page":"32877","DOI":"10.1021\/acsomega.2c03189","article-title":"Review of electrostatic force calculation methods and their acceleration in molecular dynamics packages using graphics processors","volume":"7","author":"George","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiomed.2025.111134_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109245","article-title":"A review on description dynamics and conformational changes of proteins using combination of principal component analysis and molecular dynamics simulation","volume":"183","author":"Moradi","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.111134_bib77","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202203319","article-title":"QM\/MM studies on enzyme catalysis and insight into designing of new inhibitors by ONIOM approach: recent update","volume":"8","author":"Sharma","year":"2023","journal-title":"ChemistrySelect"},{"issue":"40","key":"10.1016\/j.compbiomed.2025.111134_bib79","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.1021\/acs.jpcb.5b05897","article-title":"Insights into the nature of anesthetic\u2013protein interactions: an ONIOM study","volume":"119","author":"Qiu","year":"2015","journal-title":"J. Phys. Chem. B"},{"issue":"24","key":"10.1016\/j.compbiomed.2025.111134_bib80","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1021\/acs.jpcb.7b02079","article-title":"The role of the hydroxyl group in propofol-protein target recognition: insights from ONIOM studies","volume":"121","author":"Qiu","year":"2017","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib81","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1038\/s41467-024-48453-4","article-title":"Accelerating reliable multiscale quantum refinement of protein\u2013drug systems enabled by machine learning","volume":"15","author":"Yan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2025.111134_bib82","series-title":"Semiempirical Calculations in Computational Chemistry: Introduction to the Theory and Applications of Molecular and Quantum Mechanics","first-page":"421","author":"Lewars","year":"2016"},{"key":"10.1016\/j.compbiomed.2025.111134_bib83","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molstruc.2019.04.007","article-title":"Optimized GPU implementation of merck molecular force field and universal force field","volume":"1188","author":"J\u00e1sz","year":"2019","journal-title":"J. Mol. Struct."},{"issue":"51","key":"10.1016\/j.compbiomed.2025.111134_bib84","doi-asserted-by":"crossref","first-page":"48261","DOI":"10.1021\/acsomega.2c06373","article-title":"Benchmarking Gaussian basis sets in quantum-chemical calculations of photoabsorption spectra of light atomic clusters","volume":"7","author":"Mahamiya","year":"2022","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib85","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1038\/s41598-021-84006-1","article-title":"Computational modelling of nanotube delivery of anti-cancer drug into glutathione reductase enzyme","volume":"11","author":"Begum","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/molecules28010175","article-title":"Comprehensive survey of consensus docking for high-throughput virtual screening","volume":"28","author":"Blanes-Mira","year":"2022","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.compbiomed.2025.111134_bib87","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1007\/s12010-022-04040-1","article-title":"Interaction of bioactive compounds of Moringa oleifera leaves with SARS-CoV-2 proteins to combat COVID-19 pathogenesis: a phytochemical and in silico analysis","volume":"194","author":"Siddiqui","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.111134_bib88","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/0976500X241266072","article-title":"Molecular docking and dynamic simulation studies of bioactive compounds from traditional medicinal compounds against exfoliative toxin B from Staphylococcus aureus","volume":"15","author":"Subramani","year":"2024","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"24","key":"10.1016\/j.compbiomed.2025.111134_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413423","article-title":"A search for cyclin-dependent kinase 4\/6 inhibitors by pharmacophore-based virtual screening, molecular docking, and molecular dynamic simulations","volume":"22","author":"Susanti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2025.111134_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106449","article-title":"SARS-CoV-2 proteases Mpro and PLpro: design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations","volume":"153","author":"Tumskiy","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2025.111134_bib91","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejmech.2019.01.003","article-title":"Recent development of CDK inhibitors: an overview of CDK\/inhibitor co-crystal structures","volume":"164","author":"Cheng","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111134_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101996","article-title":"Physicochemical properties and drug likeness of hydroxycinnamic acids and their molecular docking with caffeine and amoxicillin: potential anticancer drugs","volume":"13","author":"Sherefedin","year":"2025","journal-title":"Results Chem."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.111134_bib93","first-page":"520","article-title":"Discovery of in silico pharmacokinetic characteristics, drug-likeness, computational and experimental pKa values of selected unnatural fatty acid derivatives, Phosphorus Sulfur Silicon Relat","volume":"199","author":"Aksoy","year":"2024","journal-title":"Elements"},{"key":"10.1016\/j.compbiomed.2025.111134_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2022.121043","article-title":"Seven metal-based bi-dentate NO azocoumarine complexes: synthesis, physicochemical properties, DFT calculations, drug-likeness, in vitro antimicrobial screening and molecular docking analysis","volume":"539","author":"Abdou","year":"2022","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.compbiomed.2025.111134_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2023.100118","article-title":"Herbal concoction unveiled: a computational analysis of phytochemicals' pharmacokinetic and toxicological profiles using novel approach methodologies (NAMs)","volume":"5","author":"Rai","year":"2023","journal-title":"Curr. Res. Toxicol."},{"key":"10.1016\/j.compbiomed.2025.111134_bib96","doi-asserted-by":"crossref","first-page":"i326","DOI":"10.1093\/bioinformatics\/btad222","article-title":"CProMG: controllable protein-oriented molecule generation with desired binding affinity and drug-like properties","volume":"39","author":"Li","year":"2023","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib97","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1038\/s41598-025-86809-y","article-title":"Prediction of ADMET profile and anti-inflammatory potential of chamuangone","volume":"15","author":"Jantarawong","year":"2025","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.111134_bib98","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1021\/acs.jcim.2c00372","article-title":"Optimization of an in-silico protocol using probe permeabilities to identify membrane pan-assay interference compounds","volume":"62","author":"Magalh\u00e3es","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.111134_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299301","article-title":"Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies: novel Indeno [1, 2-b] pyrrol-4 (1 H)-one as SARS-CoV-2 main protease inhibitors","volume":"19","author":"Gheidari","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75292-6","article-title":"Virtual screening, ADMET prediction, molecular docking, and dynamic simulation studies of natural products as BACE1 inhibitors for the management of Alzheimer's disease","volume":"14","author":"Gheidari","year":"2024","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.111134_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306973","article-title":"Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo [3, 2-a] pyridine-6, 8-dicarbonitrile derivatives as potential anti-diabetic agents","volume":"19","author":"Aghahosseini","year":"2024","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.compbiomed.2025.111134_bib102","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.3390\/app13106045","article-title":"Impact of cytochrome P450 enzymes on the phase I metabolism of drugs","volume":"13","author":"Iacopetta","year":"2023","journal-title":"Appl. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/med.21982","article-title":"CYP1A inhibitors: recent progress, current challenges, and future perspectives","volume":"44","author":"Dai","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.111134_bib104","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1080\/07391102.2023.2300755","article-title":"Inhibitory potential of furanocoumarins against cyclin dependent kinase 4 using integrated docking, molecular dynamics and ONIOM methods","volume":"43","author":"Sarma","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.111134_bib105","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1039\/D3RA07322J","article-title":"MolToxPred: small molecule toxicity prediction using machine learning approach","volume":"14","author":"Setiya","year":"2024","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib106","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/biom10010138","article-title":"A review of the structure activity relationship of natural and synthetic antimetastatic compounds","volume":"10","author":"Liew","year":"2020","journal-title":"Biomolecules"},{"issue":"22","key":"10.1016\/j.compbiomed.2025.111134_bib107","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3390\/math9222855","article-title":"Comparison of molecular geometry optimization methods based on molecular descriptors","volume":"9","author":"B\u00e1lint","year":"2021","journal-title":"Mathematics"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.111134_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2024.101894","article-title":"In silico evaluation of cis-dihydroxy-indeno [1, 2-d] imidazolones as inhibitors of glycogen synthase kinase-3: synthesis, molecular docking, physicochemical data, ADMET, MD simulation, and DFT calculations","volume":"28","author":"Mahmoodi","year":"2024","journal-title":"J. Saudi Chem. Soc."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.111134_bib109","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1039\/C4MB00077C","article-title":"Insights into the structural basis of 3, 5-diaminoindazoles as CDK2 inhibitors: prediction of binding modes and potency by QM\u2013MM interaction, MESP and MD simulation","volume":"10","author":"Tripathi","year":"2014","journal-title":"Mol. Biosyst."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.111134_bib110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jcc.26886","article-title":"Electrophilicity index revisited","volume":"44","author":"Pal","year":"2023","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.111134_bib111","author":"Bauer"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib112","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41598-021-83626-x","article-title":"Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein","volume":"11","author":"Opo","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.111134_bib113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s41745-019-00141-9","article-title":"Strong and weak hydrogen bonds in protein\u2013ligand recognition","volume":"100","author":"Bulusu","year":"2020","journal-title":"J. Indian Inst. Sci."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525014878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525014878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:50:38Z","timestamp":1773143438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525014878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":113,"alternative-id":["S0010482525014878"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111134","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2025-hf452","asserted-by":"object"}]},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of effective cyclin-dependent kinase 3\/cyclin E inhibitors using multi-level computational screening and simulation","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111134"}}